Summit Therapeutics
SMMT
₹1,678
Share price
-3.33%
Change (1 day)
427.48%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : ₹4.03 Billion
According to Summit Therapeutics 's latest financial reports the company's total liabilities are ₹4.03 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Summit Therapeutics - Total liabilities on balance sheet (from 2020 to 2020)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹4.01 B | -61.49% |
| 2023-12-31 | ₹10.42 B | -76.56% |
| 2022-12-31 | ₹44.47 B | 1886.01% |
| 2021-12-31 | ₹2.23 B | 32.89% |
| 2020-12-31 | ₹1.68 B | |
| 2019-01-31 | ₹2.21 B | -70.29% |
| 2018-01-31 | ₹7.45 B | 71.2% |
| 2017-01-31 | ₹4.35 B | 252.13% |
| 2016-01-31 | ₹1.23 B | 36.55% |
| 2015-01-31 | ₹0.90 B | 110.77% |
| 2014-01-31 | ₹0.42 B | 111.62% |
| 2013-01-31 | ₹0.20 B | 5.2% |
| 2012-01-31 | ₹0.19 B | 18.91% |
| 2011-01-31 | ₹0.16 B | -57.35% |
| 2010-01-31 | ₹0.38 B | -29.96% |
| 2009-01-31 | ₹0.54 B | -54.65% |
| 2008-01-31 | ₹1.19 B | 119.03% |
| 2007-01-31 | ₹0.54 B | 180.98% |
| 2006-01-31 | ₹0.19 B | 575.39% |
| 2005-01-31 | ₹28.8 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹210.17 B | 5,102.58% | 🇺🇸 USA |
 | ₹1.95 B | -51.57% | 🇺🇸 USA |
 | ₹51.17 B | 1,166.71% | 🇺🇸 USA |